Vergoeding 2018-2022 voor ATC-subgroep C08CA : Dihydropyridinederivaten
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| C08CA01 Amlodipine (Norvasc ®) | 3.575.600 | 5.151.400 | 5.527.100 | 5.680.300 | 6.130.600 |
| C08CA02 Felodipine (Plendil ®) | 569.890 | 576.850 | 556.550 | 526.320 | 507.300 |
| C08CA03 Isradipine | 48.923 | 488 | . | . | . |
| C08CA05 Nifedipine (Nifedipin-ratiopharm ®) | 6.580.200 | 7.227.700 | 6.827.700 | 6.860.600 | 7.070.500 |
| C08CA06 Nimodipine (Nimotop ®) | 16.337 | 12.952 | 15.134 | 15.344 | 14.262 |
| C08CA08 Nitrendipine | 24.733 | . | . | . | . |
| C08CA09 Lacidipine | 84.288 | 75.896 | 75.808 | 81.044 | 72.967 |
| C08CA12 Barnidipine (Cyress ®) | 17.858.600 | 18.026.600 | 18.686.600 | 19.483.700 | 20.453.900 |
| C08CA13 Lercanidipine (Lerdip ®) | 959.440 | 1.102.800 | 1.228.300 | 1.300.700 | 1.394.400 |
| Totaal | 29.718.011 | 32.174.686 | 32.917.192 | 33.948.008 | 35.643.929 |